Potential of endogenous regenerative technology for in situ regenerative medicine
Endogenous regenerative technology involves the use of a patient's biologically active proteins, growth factors and biomaterial scaffolds.
top of page
Search
- Jun 16, 2022
A new hope for a therapy against retinitis pigmentosa
June 17, 2022 | Université de Genève Journal Reference Olivier Mercey, Corinne Kostic, Eloïse Bertiaux, Alexia Giroud, Yashar Sadian,...
- Mar 17, 2022
Antabuse may help revive vision in people with progressive blinding disorders
UC Berkeley researchers have found that a drug once widely used to wean alcoholics off drinking may help improve sight in mice with RD.
- Aug 15, 2021
New Treatments for Retinitis Pigmentosa
Existing treatments only help a fraction of the estimated 100,000 Americans with this condition. But advances in gene therapy may soon help.
- Mar 15, 2021
FDA grants orphan drug designation for RP treatment
The FDA has granted orphan drug designation for chemically induced photoreceptor-like cells to treat retinitis pigmentosa.
- Jul 14, 2018
Understanding the molecular mechanisms underlying retina degeneration in INPP5E-Joubert Syndrome
Our goal is to identify the onset of degeneration and devise gene-based therapies to ameliorate or cure the retina disease.
- Mar 31, 2018
First Gene Therapy FDA-Approved for an Inherited Retinal Disease
In 1972, Friedman and Roblin proposed that it was theoretically possible to introduce “good” DNA to replace defective DNA.
- Dec 19, 2017
FDA Approves Gene Therapy for Inherited Blindness Developed by the UPenn and CHOP
In 2017, the FDA approved a gene therapy for RP caused by RPE65. The decision marked the first approved treatment for any form RP.
- Jun 30, 2013
Stem Cell Therapy: Novel Approach, RP Vision Restoration
Medical Hypothesis, Discovery Innovation Ophthalmology Journal | Harvey Siy Uy, MD, Pik Sha Chan, MD, and Franz Marie Cruz, MD | 2013...
- May 15, 2011
Scientists for the First Time Regenerate Sections of Retinas and Increase Visual Function With Stem
Fierce Biotech | May 16, 2011, 08:05 am | Boston | PRNewswire-US Newswire Scientists from Schepens Eye Research Institute are the first...
- Sep 30, 2010
Regenerative Therapy for Retinal Disorders
Discusses stem cells, dev stages of the eye field, eye field transcriptional factors, and endogenous and exogenous sources of stem cells.
All Posts
bottom of page